281 related articles for article (PubMed ID: 10571279)
21. Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution.
Miyake K; Hirayama F; Uekama K
J Pharm Sci; 1999 Jan; 88(1):39-45. PubMed ID: 9874700
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the complexes of furosemide with 2-hydroxypropyl-beta-cyclodextrin and sulfobutyl ether-7-beta-cyclodextrin.
Spamer E; Müller DG; Wessels PL; Venter JP
Eur J Pharm Sci; 2002 Sep; 16(4-5):247-53. PubMed ID: 12208454
[TBL] [Abstract][Full Text] [Related]
23. NMR spectroscopic characterization of metoprolol/cyclodextrin complexes in aqueous solution: cavity size dependency.
Ikeda Y; Hirayama F; Arima H; Uekama K; Yoshitake Y; Harano K
J Pharm Sci; 2004 Jul; 93(7):1659-71. PubMed ID: 15176056
[TBL] [Abstract][Full Text] [Related]
24. Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins.
Sharma US; Balasubramanian SV; Straubinger RM
J Pharm Sci; 1995 Oct; 84(10):1223-30. PubMed ID: 8801338
[TBL] [Abstract][Full Text] [Related]
25. Stabilizing and solubilizing effects of sulfobutyl ether beta-cyclodextrin on prostaglandin E1 analogue.
Uekama K; Hieda Y; Hirayama F; Arima H; Sudoh M; Yagi A; Terashima H
Pharm Res; 2001 Nov; 18(11):1578-85. PubMed ID: 11758766
[TBL] [Abstract][Full Text] [Related]
26. Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipine.
Yoshida A; Yamamoto M; Itoh T; Irie T; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):176-9. PubMed ID: 2337940
[TBL] [Abstract][Full Text] [Related]
27. Bicalutamide Anticancer Activity Enhancement by Formulation of Soluble Inclusion Complexes with Cyclodextrins.
De Gaetano F; Cristiano MC; Paolino D; Celesti C; Iannazzo D; Pistarà V; Iraci N; Ventura CA
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421730
[TBL] [Abstract][Full Text] [Related]
28. Complexation of the interferon inducer, bropirimine, with hydroxypropyl-beta-cyclodextrin.
Echezarreta-López M; Torres-Labandeira JJ; Castiñeiras-Seijo L; Santana-Penín L; Vila-Jato JL
Eur J Pharm Sci; 2000 Feb; 9(4):381-6. PubMed ID: 10664478
[TBL] [Abstract][Full Text] [Related]
29. Improvement of dissolution properties of a new Helicobacter pylori eradicating agent (TG44) by inclusion complexation with beta-cyclodextrin.
Anzai K; Mizoguchi J; Yanagi T; Hirayama F; Arima H; Uekama K
Chem Pharm Bull (Tokyo); 2007 Oct; 55(10):1466-70. PubMed ID: 17917290
[TBL] [Abstract][Full Text] [Related]
30. The formation of an inclusion complex between a metabolite of ginsenoside, compound K and γ-cyclodextrin and its dissolution characteristics.
Igami K; Ozawa M; Inoue S; Iohara D; Miyazaki T; Shinoda M; Anraku M; Hirayama F; Uekama K
J Pharm Pharmacol; 2016 May; 68(5):646-54. PubMed ID: 26255976
[TBL] [Abstract][Full Text] [Related]
31. Controlled release of a water-soluble drug, captopril, by a combination of hydrophilic and hydrophobic cyclodextrin derivatives.
Ikeda Y; Kimura K; Hirayama F; Arima H; Uekama K
J Control Release; 2000 May; 66(2-3):271-80. PubMed ID: 10742586
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.
Nie S; Fan X; Peng Y; Yang X; Wang C; Pan W
Arch Pharm Res; 2007 Aug; 30(8):991-1001. PubMed ID: 17879753
[TBL] [Abstract][Full Text] [Related]
33. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
Srivalli KM; Mishra B
AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
[TBL] [Abstract][Full Text] [Related]
34. Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state.
Pose-Vilarnovo B; Perdomo-López I; Echezarreta-López M; Schroth-Pardo P; Estrada E; Torres-Labandeira JJ
Eur J Pharm Sci; 2001 Jun; 13(3):325-31. PubMed ID: 11384856
[TBL] [Abstract][Full Text] [Related]
35. Characterization of itraconazole/2-hydroxypropyl-beta-cyclodextrin inclusion complex in aqueous propylene glycol solution.
Miyake K; Irie T; Arima H; Hirayama F; Uekama K; Hirano M; Okamaoto Y
Int J Pharm; 1999 Mar; 179(2):237-45. PubMed ID: 10053216
[TBL] [Abstract][Full Text] [Related]
36. Influence of the preparation method on the physicochemical properties of tolbutamide/cyclodextrin binary systems.
Veiga F; Fernandes C; Maincent P
Drug Dev Ind Pharm; 2001 Jul; 27(6):523-32. PubMed ID: 11548859
[TBL] [Abstract][Full Text] [Related]
37. Physicochemical characterization and in vitro biological evaluation of solid compounds from furazolidone-based cyclodextrins for use as leishmanicidal agents.
Carvalho SG; Cipriano DF; de Freitas JCC; Junior MÂS; Ocaris ERY; Teles CBG; de Jesus Gouveia A; Rodrigues RP; Zanini MS; Villanova JCO
Drug Deliv Transl Res; 2020 Dec; 10(6):1788-1809. PubMed ID: 32803562
[TBL] [Abstract][Full Text] [Related]
38. Effect of 2-hydroxypropyl-beta-cyclodextrin on crystallization and polymorphic transition of nifedipine in solid state.
Hirayama F; Wang Z; Uekama K
Pharm Res; 1994 Dec; 11(12):1766-70. PubMed ID: 7899242
[TBL] [Abstract][Full Text] [Related]
39. Preparation and study on the novel solid inclusion complex of ciprofloxacin with HP-beta-cyclodextrin.
Chao J; Meng D; Li J; Xu H; Huang S
Spectrochim Acta A Mol Biomol Spectrosc; 2004 Feb; 60(3):729-34. PubMed ID: 14747100
[TBL] [Abstract][Full Text] [Related]
40. (13)C and (15)N solid-state NMR studies on albendazole and cyclodextrin albendazole complexes.
Ferreira MJ; García A; Leonardi D; Salomon CJ; Lamas MC; Nunes TG
Carbohydr Polym; 2015 Jun; 123():130-5. PubMed ID: 25843843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
